4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-21-029356
CEO sold 7,850 shares at $20.33 ($159,591)
- CEO acquired 15,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2021-04-29 | Option exercise | +15,625 | 57,162 | D | ||
| DAVIS STEPHEN CEO | 2021-04-30 | Sale | −7,850 | $20.33 | $159,591 | 49,312 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2021-04-29 | Option exercise · Restricted Stock Units | −15,625 | 31,250 | D | ||
| Open-market sales · 7,850 sh · avg $20.33 · $159,591 | |||||||
Loading xslF345X03/doc4.xml…